Free tool
FAERS Monitor: Tigan
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017530 or its brand name (Tigan, Trimethobenzamide Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
1,417
Serious
494
35% of reports
Hospitalization
273
Death reported
61
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea332
- somnolence228
- dizziness166
- vomiting132
- yawning121
- drug ineffective102
- blood pressure decreased101
- fatigue93
- fall78
- blood pressure increased68
- feeling abnormal66
- drug hypersensitivity62
- asthenia60
- pain58
- dyspnoea57
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 24 |
| 2005 | 28 |
| 2006 | 30 |
| 2007 | 44 |
| 2008 | 30 |
| 2009 | 27 |
| 2010 | 32 |
| 2011 | 41 |
| 2012 | 51 |
| 2013 | 34 |
| 2014 | 22 |
| 2015 | 45 |
| 2016 | 81 |
| 2017 | 161 |
| 2018 | 214 |
| 2019 | 183 |
| 2020 | 181 |
| 2021 | 127 |
| 2022 | 31 |
| 2023 | 12 |
| 2024 | 11 |
| 2025 | 1 |
| 2026 | 7 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,742 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| yawningSignal | 121 | 705.3 | 592.2 | 80,578 |
| blood pressure decreasedSignal | 101 | 22.6 | 18.7 | 2,066 |
| somnolenceSignal | 228 | 16.8 | 14.9 | 3,407 |
| blood pressure increasedSignal | 68 | 6.6 | 5.2 | 320 |
| nauseaSignal | 332 | 6.2 | 5.7 | 1,508 |
| dizzinessSignal | 166 | 4.9 | 4.3 | 530 |
| drug hypersensitivitySignal | 62 | 4.8 | 3.7 | 182 |
| vomitingSignal | 132 | 4.2 | 3.5 | 322 |
| feeling abnormalSignal | 66 | 4.1 | 3.2 | 153 |
| fallSignal | 78 | 3.5 | 2.8 | 137 |
| astheniaSignal | 60 | 2.4 | 1.8 | 47 |
| fatigue | 93 | 1.8 | 1.5 | 32 |
| dyspnoea | 57 | 1.5 | 1.2 | 9 |
| pain | 58 | 1.4 | 1.1 | 6 |
| drug ineffective | 102 | 1.1 | 1.0 | 2 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.